The mechanisms of HBV-induced hepatocellular carcinoma
Y Jiang, Q Han, H Zhao, J Zhang - Journal of hepatocellular …, 2021 - Taylor & Francis
Hepatocellular carcinoma (HCC) is a common malignancy, and the hepatitis B virus (HBV) is
its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection …
its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection …
Hepatitis virus and hepatocellular carcinoma: recent advances
C Shen, X Jiang, M Li, Y Luo - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is a global health challenge. Hepatitis
virus infection (including HBV, HCV and HDV) is one of the major risk factors for HCC …
virus infection (including HBV, HCV and HDV) is one of the major risk factors for HCC …
Hepatitis B virus-associated hepatocellular carcinoma
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA. LI. CA database
A Vitale, G Svegliati-Baroni, A Ortolani, M Cucco… - Gut, 2023 - gut.bmj.com
Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …
inclusive definition of the whole spectrum of liver diseases associated to metabolic …
Virus-mediated cell-cell fusion
Cell-cell fusion between eukaryotic cells is a general process involved in many
physiological and pathological conditions, including infections by bacteria, parasites, and …
physiological and pathological conditions, including infections by bacteria, parasites, and …
Hepatocellular carcinoma: a narrative review on current knowledge and future prospects
B Alawyia, C Constantinou - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement Hepatocellular carcinoma is the fourth leading cause of cancer-related
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases
Emerging infectious diseases are caused by unpredictable viruses with the dangerous
potential to trigger global pandemics. These viruses typically initiate infection by utilizing the …
potential to trigger global pandemics. These viruses typically initiate infection by utilizing the …
[HTML][HTML] Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges
T Luangmonkong, W Parichatikanond… - Biochemical Pharmacology, 2023 - Elsevier
Liver fibrosis is an excessive production, aberrant deposition, and deficit degradation of
extracellular matrix (ECM). Patients with unresolved fibrosis ultimately undergo end-stage …
extracellular matrix (ECM). Patients with unresolved fibrosis ultimately undergo end-stage …
[HTML][HTML] Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
Objectives Herpesviruses are ubiquitous and after primary infection they establish lifelong
latency. The impairment of maintaining latency with short-term or long-term consequences …
latency. The impairment of maintaining latency with short-term or long-term consequences …
Epigenetic mechanisms involved in HCV-induced hepatocellular carcinoma (HCC)
P Zhao, S Malik, S **ng - Frontiers in Oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths, which
is largely caused by virus infection. About 80% of the virus-infected people develop a …
is largely caused by virus infection. About 80% of the virus-infected people develop a …